{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_alefacept",
          "name": "Alefacept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_fumaric_acid_esters",
          "name": "Fumaric acid esters"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tazarotene",
          "name": "Tazarotene"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 2
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_alefacept",
          "type": "Drug",
          "label": "Alefacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fumaric_acid_esters",
          "type": "Drug",
          "label": "Fumaric acid esters",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_acitretin",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Acitretin为治疗相关类型干扰因子，先前用于掌跖脓疱病"
        },
        {
          "source": "drug_adalimumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Adalimumab在临床上用于多种皮肤病，显示疗效"
        },
        {
          "source": "drug_alefacept",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Alefacept能够调节免疫反应，适用于皮肤病"
        },
        {
          "source": "drug_apremilast",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Apremilast调节炎症并有相关临床效果"
        },
        {
          "source": "drug_brodalumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Brodalumab通过IL-17抑制机制相关"
        },
        {
          "source": "drug_etanercept",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Etanercept用于多种自身免疫性疾病，显示有效性"
        },
        {
          "source": "drug_fumaric_acid_esters",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Fumaric acid esters已用于相关表型治疗"
        },
        {
          "source": "drug_infliximab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Infliximab在系统性免疫治疗中应用"
        },
        {
          "source": "drug_methotrexate",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Methotrexate已用于严重皮肤疾病"
        },
        {
          "source": "drug_secukinumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Secukinumab有针对性IL-17机制的效果"
        },
        {
          "source": "drug_tazarotene",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Tazarotene为类视黄醇药物用于皮肤状态"
        },
        {
          "source": "drug_ustekinumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Ustekinumab有效针对免疫相关表型"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物在机制上对 Generalised pustular psoriasis 具有支持性证据",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物对相关表型均有基础疗效（常识判断）"
    ],
    "uncertainties": [
      "不同患者对疗效的反应可能存在差异（需后续检验）"
    ],
    "next_focus_for_pi": [
      "是否需进一步调查药物间相互作用和联合疗法"
    ]
  }
}